Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect

BNCT is a non-invasive cancer therapy that allows for cancer cell death without harming adjacent cells. However, the application is limited, owing to the challenges of working with clinically approved boron (B) compounds and drug delivery systems (DDS). To address the issues, we developed self-forming nanoparticles consisting of a biodegradable polymer, namely, “AB-type Lactosome (AB-Lac)” loaded with B compounds. Three carborane isomers (o-, m-, and p-carborane) and three related alkylated derivatives, i.e., 1,2-dimethy-o-carborane (diC1-Carb), 1,2-dihexyl-o-carborane (diC6-Carb), and 1,2-didodecyl-o-carborane (diC12-Carb), were separately loaded. diC6-Carb was highly loaded with AB-Lac particles, and their stability indicated the “molecular glue” effect. The efficiency of in vitro B uptake of diC6-Carb for BNCT was confirmed at non-cytotoxic concentration in several cancer cell lines. In vivo/ex vivo biodistribution studies indicated that the AB-Lac particles were remarkably accumulated within 72 h post-injection in the tumor lesions of mice bearing syngeneic breast cancer (4T1) cells, but the maximum accumulation was reached at 12 h. In ex vivo B biodistribution, the ratios of tumor/normal tissue (T/N) and tumor/blood (T/Bl) of the diC6-Carb-loaded particles remained stably high up to 72 h. Therefore, we propose the diC6-Carb-loaded AB-Lac particles as a promising candidate medicine for BNCT.

[1]  S. Kimura,et al.  Downsizing to 25-nm reverse polymeric micelle composed of AB3-type polydepsipeptide with comprising siRNA , 2022, Chemistry Letters.

[2]  F. Du,et al.  Carboranes as unique pharmacophores in antitumor medicinal chemistry , 2022, Molecular therapy oncolytics.

[3]  F. Hausch,et al.  Clues to molecular glues , 2021, Current Research in Chemical Biology.

[4]  Anaïs Pitto‐Barry.  Polymers and boron neutron capture therapy (BNCT): a potent combination , 2021, Polymer Chemistry.

[5]  R. Dwyer,et al.  Boron clusters as breast cancer therapeutics. , 2021, Journal of inorganic biochemistry.

[6]  T. Ohtsuki,et al.  A Novel 89Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): “Lactosome” Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy , 2021, Life.

[7]  T. Ohtsuki,et al.  Lactosome-conjugated siRNA nanoparticles for photo-enhanced gene silencing in cancer cells. , 2021, Journal of pharmaceutical sciences.

[8]  S. Miyatake,et al.  The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model , 2020, Biology.

[9]  H. Matsui,et al.  Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture t (BNCT). , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[10]  J. Heng,et al.  Surface hydrophobicity: effect of alkyl chain length and network homogeneity , 2020, Frontiers of Chemical Science and Engineering.

[11]  S. Geninatti Crich,et al.  In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells , 2020, Scientific Reports.

[12]  Minoru Suzuki,et al.  Cyclic RGD-Functionalized closo-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture Therapy. , 2020, Molecular pharmaceutics.

[13]  M. Dong,et al.  Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation , 2020, bioRxiv.

[14]  Minoru Suzuki,et al.  Evaluation of a Novel Boron-Containing α-d-Mannopyranoside for BNCT , 2020, Cells.

[15]  F. Ali,et al.  Boron Chemistry for Medical Applications , 2020, Molecules.

[16]  Yongmin Chang,et al.  PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT). , 2019, Biochemical and biophysical research communications.

[17]  John A. Tallarico,et al.  Manumycin Polyketides Act as Molecular Glues Between UBR7 and P53 , 2019, bioRxiv.

[18]  E. Ohno,et al.  Novel single‐chain variant of antibody against mesothelin established by phage library , 2019, Cancer science.

[19]  E. Hey‐Hawkins,et al.  New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies. , 2019, Chemical Society reviews.

[20]  Zargham Emilia O,et al.  The Use of Carboranes in Cancer Drug Development , 2019, International Journal of Cancer and Clinical Research.

[21]  Ratna Dwi Ramadani,et al.  Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cells , 2019, Investigational New Drugs.

[22]  P. Mi,et al.  Boron delivery agents for neutron capture therapy of cancer , 2018, Cancer communications.

[23]  A. Schroeder,et al.  Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems. , 2018, Chemical engineering journal.

[24]  Y. Takai,et al.  Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy , 2018, Journal of radiation research.

[25]  K. Makino,et al.  Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy. , 2017, Colloids and surfaces. B, Biointerfaces.

[26]  Lijie Duan,et al.  The effect of hydrophobic alkyl chain length on the mechanical properties of latex particle hydrogels , 2017 .

[27]  H. Tsuji,et al.  Configurational Molecular Glue: One Optically Active Polymer Attracts Two Oppositely Configured Optically Active Polymers , 2017, Scientific Reports.

[28]  K. Togashi,et al.  Inflammation-induced synergetic enhancement of nanoparticle treatments with DOXIL® and 90Y-Lactosome for orthotopic mammary tumor , 2016, Journal of Nanoparticle Research.

[29]  S. Miyatake,et al.  The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model , 2015, PloS one.

[30]  Hiroyuki Nakamura,et al.  Boron-Based Drug Design. , 2015, Chemical record.

[31]  S. Kimura,et al.  Factors influencing in vivo disposition of polymeric micelles on multiple administrations. , 2014, ACS medicinal chemistry letters.

[32]  Kensuke Kurihara,et al.  Evasion from accelerated blood clearance of nanocarrier named as "Lactosome" induced by excessive administration of Lactosome. , 2013, Biochimica et biophysica acta.

[33]  M. Hawthorne,et al.  Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes , 2013, Proceedings of the National Academy of Sciences.

[34]  Kensuke Kurihara,et al.  Pharmacokinetic change of nanoparticulate formulation "Lactosome" on multiple administrations. , 2012, International immunopharmacology.

[35]  Shinji Kawabata,et al.  Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer , 2012, Radiation oncology.

[36]  Y. Nagasaki,et al.  Boron neutron capture therapy assisted by boron-conjugated nanoparticles , 2012 .

[37]  E. Hey‐Hawkins,et al.  Carbaboranes as pharmacophores: properties, synthesis, and application strategies. , 2011, Chemical reviews.

[38]  R. Kuroki,et al.  Crystal Structure Analysis of Poly(l-lactic Acid) α Form On the basis of the 2-Dimensional Wide-Angle Synchrotron X-ray and Neutron Diffraction Measurements , 2011 .

[39]  Y. Nagasaki,et al.  Carborane confined nanoparticles for boron neutron capture therapy: Improved stability, blood circulation time and tumor accumulation , 2011 .

[40]  M. Kassiou,et al.  Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds. , 2011, Chemical reviews.

[41]  Jürgen Groll,et al.  Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. , 2010, ACS nano.

[42]  Akira Makino,et al.  Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. , 2009, Biomaterials.

[43]  V. Bertolasi,et al.  Predicting hydrogen-bond strengths from acid-base molecular properties. The pK(a) slide rule: toward the solution of a long-lasting problem. , 2009, Accounts of chemical research.

[44]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[45]  Eunji Lee,et al.  Lateral association of cylindrical nanofibers into flat ribbons triggered by "molecular glue". , 2008, Angewandte Chemie.

[46]  Youngjoo Byun,et al.  Carboranyl thymidine analogues for neutron capture therapy. , 2007, Chemical communications.

[47]  Andrea F Armstrong,et al.  The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. , 2007, Dalton transactions.

[48]  S. Kimura,et al.  Preparation of novel polymer assemblies, "lactosome", composed of Poly(L-lactic acid) and poly(sarcosine) , 2007 .

[49]  Monty Liong,et al.  Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells , 2007, Nanobiotechnology : the journal at the intersection of nanotechnology, molecular biology, and biomedical sciences.

[50]  Y. Endo,et al.  Chemistry of Boron Clusters, Carboranes Synthesis, Structure and Application for Molecular Construction , 2007 .

[51]  C. Powell,et al.  Closo --> nido cage degradation of 1-(substituted-phenyl)-1,2-dicarbadodecaborane(12)s in wet DMSO under neutral conditions , 2007 .

[52]  M. Vicente,et al.  Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects , 2005, Clinical Cancer Research.

[53]  T. Asakura,et al.  Helix Distortion and Crystal Structure of the α-Form of Poly(l-lactide) , 2003 .

[54]  J. Howard,et al.  Definitive crystal structures of ortho-, meta- and para-carboranes: supramolecular structures directed solely by C–H⋯O hydrogen bonding to hmpa (hmpa = hexamethylphosphoramide) , 1996 .

[55]  L. Leites.  Vibrational spectroscopy of carboranes and parent boranes and its capabilities in carborane chemistry , 1992 .

[56]  C. Reichardt.  Solvents and Solvent Effects in Organic Chemistry , 1988 .